|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.130 USD | -4.86% |
|
-6.29% | -14.48% |
| 05-14 | Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Journey Medical Corporation secures contract with third major GPO for Emrosi | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 3.75 | 3.75 | 4.3 |
| Spread/Res. | -16.53% | -16.53% | -27.21% |
| Spread/Supp. | +13.41% | +40.99% | +34.33% |
| Support | 2.76 | 2.22 | 2.33 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- FBIO Stock
- Charts Fortress Biotech, Inc.
Select your edition
All financial news and data tailored to specific country editions
